Hanmi Pharmaceutical
8
8M
7
0.16
3
0.12
2
- Areas of investment
Summary
Hanmi Pharmaceutical is the famous Corporate Investor, which was founded in 1973. The main department of described Corporate Investor is located in the Seoul. The venture was found in Asia in South Korea.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Darmiyan, Allegro Ophthalmics. The fund has exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Enterprise Software, Biotechnology.
The top activity for fund was in 2015. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Hanmi Pharmaceutical, startups are often financed by Y Combinator, Center of Aging and Brain Health Innovation, Berkeley SkyDeck. The meaningful sponsors for the fund in investment in the same round are Wei Guo, UpHonest Capital, Soma Capital.
The fund was created by Sung-ki Lim.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 3
- Exits
- 2
- Rounds per year
- 0.16
- Follow on index
- 0.12
- Investments by industry
- Biotechnology (5)
- Health Care (4)
- Pharmaceutical (3)
- Biopharma (3)
- Clinical Trials (3) Show 14 more
- Investments by region
-
- United States (4)
- Canada (2)
- South Korea (2)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 8M
- Group Appearance index
- 0.50
- Avg. company exit year
- 14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bloomlife | 17 Jul 2018 | Monitoring Equipment, Other Healthcare Technology Systems, Artificial Intelligence, Fitness, Health Care, Wellness, mHealth, Wearables | Seed | 4M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.